GlassScriptPhysician profile
Ashley N Howell
NPI 1467957621
$1,737.12
in general payments reported to CMS, 2019-2025
7 companies · $749 in 2025
The $749 reported for 2025 was more than what 83% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $989 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572 · Travel and Lodging: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,571.72 |
| Travel and Lodging | $165.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $820.66 | 2024-2025 | Embold Fibered, Cryoablation Needles, Icefx Cryoablation System |
| Sirtex Medical INC | $412.12 | 2024-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Inari Medical, INC. | $256.15 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $140.94 | 2024 | Azur Cx Detachable |
| Stryker Corporation | $54.17 | 2025 | Flowtriever |
| Teleflex LLC | $31.46 | 2025 | Turnpike, Guideliner |
| Abiomed | $21.62 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.